Table 1 Baseline participant demographics

From: Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer

n = 10 Range Mean (SD)
Age 51–83 64.4 (10.3)
  Category n %
Sex Female 6 60
Male 4 40
Income
(thousands)
< 20 1 10
40–59.9 2 20
60–79.9 1 10
> 80 5 50
Not specified 1 10
Education Some high school 1 10
Completed high school 1 10
Some university/college 3 30
Completed university/college 3 30
Some graduate school 2 20
Marital Status Married/common Law 8 80
Divorced/separated 1 10
Widowed 1 10
Employment Status Retired 6 60
Disability/sick leave 4 40
Cancer Staging Stage IV 10 100
Tumour Marker PD-L1 High 6 60
EGFR activating mutation + 5 50
ALK translocation + 1 10
Treatment Tyrosine Kinase Inhibitor 6 60
Immune Checkpoint Inhibitor 2 20
Immune Checkpoint Inhibitor + Chemotherapy 1 10
None 1 10
Treatment Duration 0–3 months 5 50
3–6 months 2 20
> 6 months 2 20
N/A 1 10
  1. Income listed in Canadian dollars. Treatment duration is calculated from treatment start date to pre-intervention assessment date. PD-L1 Programmed-death ligand 1, EGFR, Epidermal Growth Factor receptor, ALK Anaplastic lymphoma kinase